The Uromigos Unveil Updates and Insights on the Impact of COVID-19 on GU Cancers

Welcome to a very special edition of OncLive^® On Air! I’m your host today, Gina Columbus.

OncLive^® On Air is a podcast from OncLive^®, which provides oncology professionals with the resources and information they need to provide the best patient care. In both digital and print formats, OncLive^® covers every angle of oncology practice, from new technology to treatment advances to important regulatory decisions.

But today, we had the pleasure of sitting down with members of Uromigos, a group of genitourinary (GU) cancer oncologists from all over the world who share their oncologic insights through their collaborative Twitter account and in the form of their own podcasts.

In an effort to share some of the evolving knowledge about the virus and how it is impacting the healthcare system on a global scale, the Uromigos group has discussed statistics, strategies, and new studies as they relate to COVID-19 and patients with cancer.

The account is run by Brian Rini, MD, of Vanderbilt-Ingram Cancer Center; Thomas Powles, MD, MBBS, MRCP, of Barts Cancer Institute; Silke Gillessen, MD, of the University of Manchester; David F. McDermott, MD, of Beth Israel Deaconess Medical Center; Christopher Sweeney, MBBS, of Dana-Farber Cancer Institute; Srikala Sridhar, MD, MSc, FRCPC, of Princess Margaret Cancer Centre; Laurence Albiges, MD, PhD, ‎of Gustave Roussy Institute; and Cristina Suárez Rodriguez, MD, of Hospital Quirón Barcelona.

In today’s episode of OncLive^® On Air, Drs. Rini, Powles, Sweeney, Gilessen, and Albiges came on to chat further about their perspectives on caring for patients with GU cancers and how management has evolved from early pandemic days to now, as well as looking ahead to the future when we can all eventually return to a state of normalcy.

https://twitter.com/Uromigos

https://podcasts.apple.com/us/podcast/the-uromigos/id1499514920

For more on The Uromigos, visit and .